(marketscreener.com) MorphoSys to Complete Transformational Acquisition of Constellation Pharmaceuticals, Bolstering Its Position in Hematology-Oncology Company Announces Successful Completion of Tender Offer Moves Forward with Strategic Funding Partnership with Royalty Pharma MorphoSys...https://www.marketscreener.com/quote/stock/MORPHOSYS-AG-436425/news/MorphoSys-nbsp-to-Complete-Transformational-Acquisition-of-Constellation-Pharmaceuticals-Bolsteri-35865525/?utm_medium=RSS&utm_content=20210715
Constellation is a Massachusetts-based biopharmaceutical company that researches, develops and commercializes novel therapeutics for the treatment of cancer.